Deep Intelligence Across Industries

COMPANY OVERVIEW Company Headquarters: Pennsylvania, US Founded: 1889 Workforce: 4,800 Company Working: Carpenter Technology Corporation (Carpenter Technology) is a leading manufacturer of high-performance specialty alloys and process solutions for various industries including automotive, aerospace, defense, energy, medical and consumer electronics. The company operates its business through two segments, namely specialty alloys operations, and performance engineered products. The specialty alloy operations segment offers cast/wrought and powder stainless steels, high temperature (nickel, cobalt, and iron-base) superalloys, high-strength steel, and tool & die steels. The company has manufacturing facilities and distribution centers located across the US, Sweden, Canada, Singapore, China, Mexico, Taiwan, UAE, and Belgium. In 2018, the expenditure incurred on research and development was USD 19.3 million.

COMPANY OVERVIEW Company Headquarters: Essen, Germany Founded: 1994 Workforce: ~1,800 Company Working: thyssenkrupp Aerospace Germany GmbH (thyssenkrupp Aerospace) is a partner of the world’s leading aerospace companies and their supply chains. The company operates through the materials and services divisions. The material division offers aluminum, steel, titanium, and other materials, whereas the services division offers material services provision, value-added services, supply chain management of finished parts, third-party logistics, and kitting. In the material division, under the other materials segment, the company offers cobalt and nickel alloys. In addition, it offers materials with value-added services and logistical services. thyssenkrupp Aerospace marks presence in more than 44 locations in around 20 countries. Furthermore, the locations have been approved to EN/AS 9100 and/or EN/AS 9120 standards by the major leading aerospace certification companies

COMPANY OVERVIEW Company Headquarters: Mumbai, India Founded: 1987 Workforce: ~ 36 Company Working: Supreme Engineering Ltd (Supreme Engineering) is engaged in the manufacturing of special alloys and special wire products. The company operates through two divisions, namely specialty steels, and wire. Under the specialty steels division, it offers nickel-based superalloys that are used in high-temperature applications in the aerospace and oil & gas industries. Also, it has expanded its operations by investing in high-end technology and is equipped with advanced technologies, which include argon-oxygen decarburization (AOD), radial forging machine (GFM), vacuum induction melting (VIM), electro-slag refining (ESR), rolling mill, and heat treatment furnaces for manufacturing special alloys.

Company Headquarters: Seoul, South Korea Founded: 1970 Workforce: ~1,200 Company Working: Kumho Petrochemical is one of the leading manufacturers of synthetic rubber and operates through the synthetic rubber, synthetic resins, and others business segments. The others segment includes specialty chemicals, electronic materials, nanocarbon, and energy business segments. The company has 13 manufacturing plants located in South Korea and China with 12 sales offices across the globe. Kumho Petrochemical has two research centers in South Korea and invested around 0.18 billion in R&D in 2017. It had over 11 subsidiaries and assets worth USD 4.29 billion as of 2017. It offers vulcanization accelerators and antioxidants under its specialty chemicals business. It produces nearly 83,500 MT per year of vulcanization accelerators.

COMPANY OVERVIEW Company Headquarters: Burton upon Trent, UK Founded: 1778 Workforce: ~4,449 Company Working: Doncasters Group Ltd (Doncasters Group) is the leading global manufacturer of high-precision alloy components, which are designed to operate in harsh conditions. The company operates through various segments, including aerospace, industrial gas turbine, superalloys, specialty automotive, and petrochemical. Under the superalloys segment, it offers iron-, cobalt-, and nickelbased alloys. With 240 years of experience, the company is constantly enhancing its products to cater to the demand in the aerospace, automotive, and oil & gas industries. In addition, it offers precision casting, forging, fabrication, and machining processes. It has two core facilities engaged in the manufacturing of superalloys, which are further used in high-performance applications such as turbine blades, hot-end turbocharger wheels, vanes, and components for aero engines and land-based gas turbines.

FCFC is Taiwan's largest integrated aromatics-to-polymers producer. It sits mid-stream in the Formosa Plastics Group's Mailiao complex, taking naphtha-derived feedstock from Formosa Petrochemical. It converts that feedstock into paraxylene, orthoxylene, benzene, styrene monomer, phenol/acetone, PTA and PIA, and then into PS, ABS, PP and PC resins. A legacy fibre and textile tail, including Formosa Taffeta, remains. Revenue fell from NT$379.9bn (FY2022) to NT$287.0bn (FY2025). The decline came as Chinese capacity additions collapsed spreads, and FY2025 brought the first annual loss since the 1984 listing. FCFC's equity value is dominated by its investment portfolio rather than its operating margin. The portfolio includes about 24% of Formosa Petrochemical and stakes in Nan Ya Plastics, Nanya Technology and other group companies. Since mid-2025 management has run a "slimming" programme that exits red-ocean commodity lines. In parallel it is pivoting toward semiconductor-grade materials, low-carbon hydrogen, green power and AI-data-centre sites. Its stated ambition is for these to reach 40–50% of revenue by 2030. --- ### What the company does FCFC manufactures and sells commodity and semi-specialty petrochemicals, plastics resins and fibre/textile products. The TWSE English company profile (generated 12 February 2026) lists its main business as petrochemical products: PTA, PS, AN, butadiene, SM polymers, SM, benzene, toluene, PX and OX, nylon fibre and spinning. The Taiwan commercial registry lists the operating scope as PTA, PS, SM, OX, PX, benzene, phenol, acetone, PP, DMF, ABS, synthetic fibre yarn and fabric, nylon filament and fabric, and dyeing/finishing. Some fibre lines, notably Taiwan rayon and spinning, were terminated in 2024, so the registry scope is broader than current operations. ### Business model and revenue model The revenue model is almost entirely product sales, priced off Asian spot and contract benchmarks: PX/OX/benzene against naphtha, PTA against PX, SM against benzene and ethylene, phenol/acetone against benzene and propylene, and resins against monomers. Profitability is a spread business. Management's monthly MOPS revenue explanations decompose every change into a "volume variance" and a "price variance". There is no meaningful subscription or licensing income. Smaller service-type revenue is emerging from four areas: - green-power wheeling and renewable-energy certificate (REC) transfer and power trading; - micro-grid/EMS integration; - small-hydro generation; - prospective leasing of land, buildings and power capacity for AI computing centres. A large and highly variable share of pre-tax profit comes from non-operating items. Equity-method income from Formosa Petrochemical (FPCC), Mailiao Power (MLPC) and Formosa Ha Tinh (FHI), dividend income from FVOCI holdings and FX are the main components. In FY2023 FCFC reported a consolidated operating loss of NT$3.1bn but a pre-tax profit of NT$7.4bn, entirely because of NT$10.5bn of non-operating profit (FCFC results deck, Apr 2025). ### Value-chain position FCFC's position in the chain runs as follows: **Upstream feedstock:** FPCC supplies naphtha and reformate under group arrangements, and FCFC returns raffinate to FPCC. MOPS revenue notes for September and November 2025 reference raffinate resold to FPCC. **Aromatics:** ARO-1/2/3 at Mailiao produce PX, OX and benzene. **First derivatives:** These are SM, phenol/acetone, PTA (Mailiao, Longde and Ningbo) and PIA. **Polymers:** These are PS, ABS, PP, and PC through Formosa Idemitsu Petrochemical. **Downstream:** These are nylon filament and fabric, and (via Formosa Taffeta) nylon/polyester fabrics and tire cord. ### Customer types and end-markets | Product family | Typical customers | End-markets | |---|---|---| | PX | PTA producers, increasingly in mainland China | Polyester fibre, PET bottle resin | | PTA / PIA | Polyester fibre & resin makers | Textiles, packaging, PET bottles | | SM | PS/ABS/SBR/UPR producers | Packaging, appliances, rubber | | Phenol / acetone | BPA, phenolic resin, MMA producers | Polycarbonate, epoxy, construction | | PS / ABS | Moulders, appliance OEMs, electronics housings | Appliances, IT housings, toys, automotive | | PP (incl. metallocene grades in development) | Converters; semiconductor carrier makers (FOUP/FOSB) | Packaging, automotive, semiconductor logistics | | PC (FIPC) | Compounders, electronics | Electronics, automotive, optical | | Engineering compounds / flame-retardant plastics | AI-server rack makers, drone makers | AI infrastructure, UAVs, 5G/6G | | Nylon / textiles (FCFC, Formosa Taffeta) | Garment & industrial-fabric makers | Apparel, tire cord, industrial | | Electricity / RECs | Corporates seeking green power | Corporate decarbonisation | ### Independent characterisation FCFC is in practice a levered call on Asian aromatics and styrenics spreads, wrapped around a large holding company. On the operating side it has been structurally unprofitable at the EBIT line since FY2022: operating margin was −1.39%, −0.92%, −0.45% and −1.41% in FY2022–FY2025. Chinese integrated refiners such as Hengli, Rongsheng/ZPC and Shenghong added PX/PTA/SM/phenol capacity far faster than demand grew over this period. On the holding side, its stakes in FPCC (about 24%), Nanya Technology, Nan Ya Plastics and others carry large mark-to-market value. The 2025–2026 memory super-cycle and oil spike pushed 1H2026 comprehensive income to NT$181.2bn against net profit of NT$13.05bn. The 2026 earnings recovery has two drivers. Exogenous oil and spread support came from the US–Iran conflict and the Strait of Hormuz disruption. Equity-method income from FPCC also surged. The "new business" pivot is real but sub-scale today. The one product with stated volumes is flame-retardant AI-server-rack plastic at 500–600 tonnes per month.

Company Headquarters: Amsterdam, The Netherlands Founded: 2006 Workforce: ~3,300 Company Working: AMG Advanced Metallurgical Group (AMG) is one of the leading producers of specialty metals, alloys, and materials. It operates through two segments, namely AMG Critical Materials and AMG Engineering. Under the AMG Critical Materials segment, the company offers various materials, aluminum, lithium, antimony, superalloys, and silicon metal, among others. AMG Superalloys UK, a production site for superalloys, offers various nickel-based alloys that find applications in the automotive, aerospace, energy, and electronic industries. It operates through the production facilities spread across Germany, France, the UK, Mexico, the US, the Czech Republic, Brazil, India, Sri Lanka, and Mozambique as well as sales offices in Russia and Japan.

COMPANY OVERVIEW Company Headquarters: Luxembourg Founded: 2011 Workforce: ~9,800 Company Working: Aperam is a leading manufacturer of stainless, electrical, and specialty steel. It is the fourth-largest producer of specialty alloys in the world. The company operates through three business segments—stainless & electrical steel, services & solution, and alloys & specialties. Through the specialty alloys essentials sub-segment, under the alloys & specialties segment, it offers nickel and cobalt alloys that are high-performance alloys exhibiting anti-corrosion, thermal expansion control characteristics, and hightemperature resistance. The production site of Aperam in Imphy, France, offers nickel and cobalt alloys, along with certain specific stainless steels. It has an industrial distribution network consisting 14 Steel Service Centers (SSCs), 17 sales offices, and six transformation facilities. Aperam has customer bases in over 40 countries and sells its products to the customers in the aerospace, construction, electrical, medical, and oil & gas industries.

COMPANY OVERVIEW Company Headquarters: Pennsylvania, US Founded: 1996 Workforce: 8,800 Company Working: Allegheny Technologies Inc (ATI) is a global manufacturer of specialty materials and complex components. The company operates its business through two business segments, i.e., high-performance materials & components (HPMC) and flatrolled products (FRP). Under the HPMC segment, ATI offers high-performance materials, nickel-based alloys and superalloys, in long product forms such as ingot, billet, bar, rod, wire, shapes and rectangles, and seamless tubes, plus precision forgings and castings, and machined parts for end markets as aerospace and defence, oil and gas, chemical, electrical and medical industries. The FRP segment produces and distributes several forms of superalloys including plate, sheet, engineered strip, and precision rolled strip products. The company has manufacturing facilities located in the US, the UK, Poland, and China, along with sales presence across the US, China, Singapore, Japan, South Korea, Taiwan, India, France, Italy, Germany, Norway, Spain, UK, South Africa, and the Middle Eastern countries.

Company Headquarters: Tel Aviv-Yafo, Israel Founded: 1968 Workforce: ~12,600 Company Working: Israel Chemicals Ltd (ICL), together with its subsidiaries, is involved in the production of magnesium hydroxide. The company operates through two business segments—namely essential minerals and specialty solutions. The essential minerals segment is further divided into potash and magnesium, phosphate, and specialty fertilizers. The specialty solutions segment is further sub-segmented into industrial products, advanced additives, and food specialties. Under specialty solutions, its subsidiary, ICL Industrial Products, produces magnesium oxide and is a global leader in specialty magnesia which is used in agriculture, construction, environmental, and general chemical grades. It sells its products through marketing companies, agents, and distributors.

COMPANY OVERVIEW Company Headquarters: Indiana, US Founded: 1912 Workforce: ~1,157 Company Working: HAYNES INTERNATIONAL (Haynes International) is one of the leading manufacturers and distributors of highperformance nickel‐ and cobalt‐based alloys for corrosion resistant and high-temperature applications. The company offers alloys in various forms including sheet, plate, bar, billet, seamless and welded pipe and tubing, fittings and flanges. It supplies high-performance alloys to the aerospace, power, chemical, wastewater treatment, and pharmaceutical industries. It operates through two business segments, namely corrosion-resistant alloys and high-temperature resistant alloys. Under the high-temperature resistant alloys segment, the company offers superalloys for hot sections of gas turbine engines in the aerospace and energy industries. Through the corrosion-resistant alloys segment, it offers superalloys for chemical processing and power plant emissions control. The high performance alloys are majorly sold under the brand names HAYNES and HASTELLOY. The company has six manufacturing facilities located in the US, and direct sales presence across the US, China, Japan, Singapore, the UK, Italy, France, and Switzerland.

Company Headquarters: Kagawa, Japan Founded: 1947 Workforce: ~24 Company Working: Kyowa Chemical Industry Co., Ltd (Kyowa) is engaged in the production and marketing of magnesium hydroxide. The magnesium hydroxide is utilized in a wide range of applications, including industrial, pharmaceutical and food additives. The company accounted for sales revenue worth USD 190.0 Million in 2018.

Company Headquarters: Texas, US Founded: 1994 Workforce: ~300 Company Working: SPI Pharma (SPI) is a subsidiary company of Associated British Foods plc (ABF), it is a part of ABF Ingredients division. SPI Pharma offers a wide range of magnesium hydroxide powders that vary in particle size and density. The company provides innovative solutions for the pharmaceutical and nutritional industries. SPI’s product line comprises antacid actives, compressible calcium powders, drug delivery systems, vaccine adjuvants, functional excipients, and taste-masked actives. The company distributes and sells its products through distributors and agents in North America, Europe, and the Middle East & Africa. The company has operations in France, the US, and India. SPI reported a sale of USD 139.31 million by the end of 2018.

| Item | Detail | |---|---| | Legal name | UBE Corporation (UBE株式会社) | | Former names | Ube Industries, Ltd. / 宇部興産株式会社 (1942 – March 2022) | | Origins / founding year | 1897 (Okinoyama Coal Mine, a silent partnership). The current corporation was incorporated in March 1942 through the merger of four Ube companies. | | Incorporation jurisdiction | Japan | | Registered head office | 1978-96 Oaza Kogushi, Ube City, Yamaguchi Prefecture, Japan | | Tokyo head office (operational HQ) | Seavans North Building, 1-2-1 Shibaura, Minato-ku, Tokyo | | Stock exchange / ticker | Tokyo Stock Exchange Prime Market: 4208. Also quoted OTC in the US (UBEOF) and in Frankfurt (UBE); both are secondary quotations. Disclosures from 2023 also referenced a Fukuoka Stock Exchange listing; the FY2026 Yuho lists only the TSE. | | ISIN / LEI | ISIN JP3158800007; LEI 529900XMRZ2VNF3ZPS69. CUSIP: not applicable (no US primary listing). | | Fiscal year end | 31 March | | Share capital | JPY 58,435 million | | Shares issued / treasury | 106,200,107 issued; 9,054,915 treasury shares (31 March 2026); about 97.15 million outstanding | | Employees (consolidated) | 7,968 at 31 March 2026. Trend: 7,882 (FY2024), 7,563 (FY2025), 7,968 (FY2026). The FY2026 increase came mainly from the LANXESS Urethane Systems acquisition. | | Employees (parent only) | 2,778 at 31 March 2026; average age 43.4 years, average tenure 15.3 years, average salary JPY 7.75 million | | Auditor | EY ShinNihon LLC; 57 years of continuous audit; FY2026 group audit fees JPY 182 million | | Market capitalisation | About JPY 306 billion, computed as JPY 3,147 close on 7 October 2026 × about 97.15 million shares outstanding excluding treasury. MarketScreener showed JPY 307 billion. | | Credit rating | JCR long-term issuer rating A (Stable), CP J-1; affirmed 30 January 2026 | | Website | https://www.ube.com | | President & CEO | Yuki Nishida (since 1 April 2025) | | Chairman | Masato Izumihara (non-executive chairman since 1 April 2025) | The entity profiled is UBE Corporation (UBE株式会社), the Japanese specialty-chemicals and machinery group formerly known as Ube Industries, Ltd. (宇部興産株式会社). This is an exact legal-name match for the input "UBE Corporation". The input listing type, "Public company", is confirmed. UBE is listed on the Prime Market of the Tokyo Stock Exchange. UBE Corporation is a 129-year-old Japanese chemicals and machinery group in the middle of a deliberate transformation from a coal-, ammonia- and caprolactam-anchored commodity producer into a global specialty-chemicals company. Its competitive core is a set of vertically integrated technology chains. The polyimide chain runs from BPDA monomer to UPILEX film, varnish and hollow-fibre gas-separation membranes. The C1 chain runs from proprietary gas-phase dimethyl carbonate (DMC) technology to polycarbonate diols, battery-grade carbonates and, since April 2025, the urethane prepolymer systems acquired from LANXESS. Silicon-nitride ceramics and lithium-ion battery separators (via 66%-owned Ube Maxell) complete the specialty portfolio. UBE also owns UBE Machinery, a die-casting and moulding-machine maker being prepared for IPO, and a 50% stake in Mitsubishi UBE Cement, Japan's No. 2 cement producer, which applied for a TSE listing in July 2026. FY2026 sales were JPY 462.3 billion and operating profit JPY 18.9 billion. Management targets JPY 100 billion+ EBITDA and ROE of 8%+ by FY2030. --- ### What the company does UBE manufactures and sells a broad range of chemical products and, through UBE Machinery, industrial machinery. From FY2026 it reports six segments: **Functional Products:** (機能品; called "Specialty Products" in some English materials): polyimide, separation membranes, ceramics, separators, phenolic resin, semiconductor gases. **High Performance Urethanes:** (高機能ウレタン): the urethane systems acquired from LANXESS, plus legacy high-performance coatings (polycarbonate diol, PCD, and polyurethane dispersion, PUD). **Pharmaceutical:** (医薬): drug discovery plus contract development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. **Resins & Chemical Products:** (樹脂・化成品; called "Polymers & Chemicals" in English materials): composites, nylon polymers, caprolactam and ammonium sulphate, industrial chemicals, C1 chemicals, elastomers. **Machinery:** (機械): die-casting machines, extrusion presses, injection-moulding machines, industrial machinery, bridges and steel structures, after-sales service. **Others:** (その他): electric power supply from in-house coal-fired generation, real estate, overseas sales companies. The cement business is not consolidated. Since 1 April 2022 it has sat inside Mitsubishi UBE Cement Corporation (MUCC), a 50:50 equity-method joint venture with Mitsubishi Materials. MUCC's contribution appears in "equity in earnings of affiliates" below operating profit: JPY 12.6 billion in FY2026 and JPY 15.6 billion in FY2025 (Source: FY2026 results presentation, 13 May 2026). ### Company's own description (FY2026 Yuho, paraphrased) The Yuho describes the group as 77 companies (the parent plus 76 affiliates at 31 March 2026). It states its purpose as "Breaking Through with the Chemistry of Hope" (希望ある化学で、難題を打ち破る) and its 2030 vision as becoming "a specialty chemicals company contributing to the global environment, people's health and an enriched future society." The medium-term plan "UBE Vision 2030 Transformation – 2nd Stage" (FY2025–FY2030 in company labelling) sets five materialities: 1. Expansion of specialty businesses 2. Activation of diverse human resources 3. Occupational safety and process safety 4. Response to global environmental issues 5. Sincere and fair corporate governance ### Business model and revenue model UBE's revenue is overwhelmingly product sales. The Yuho states that chemical revenue is recognised on delivery or risk transfer, while long-dated machinery contracts are recognised over time using an input (cost-to-cost) method. Four secondary revenue streams matter at the margin: 1. **Technology licensing.** UBE licenses its DMO (dimethyl oxalate) and MEG (monoethylene glycol) production technology to roughly 25 Chinese coal-chemical producers, with contracts dated 2010–2020. It also licenses DMC and DMC/EMC technology to at least 12 Chinese counterparties (2015–2024), and polyimide and separator technology to Panasonic Industry, SUMaterials and Ube Maxell. Management flagged lower C1 licence income as a FY2027 headwind. 2. **Machinery after-sales service.** This is described as a stable, recurring, high-margin stream, and was the main profit stabiliser in Machinery during FY2025–FY2026. 3. **Pharmaceutical royalties and contract manufacturing.** Royalty income declined in FY2025. 4. **Electricity sales** from the Ube coal-fired power plant to external customers, including MUCC's cement plants. No subscription revenue is disclosed. The product-versus-service mix is not disclosed numerically. Machinery after-sales and licence income are not broken out separately. ### Value-chain position UBE sits in the upstream-to-midstream part of the chemical value chain. - In the polyimide chain it is fully integrated from monomer (BPDA, biphenyl tetracarboxylic dianhydride) to film, varnish and hollow fibre, through to finished gas-separation modules. - In C1 it owns the core catalytic process (gas-phase methyl-nitrite route to DMC). It sells merchant DMC/EMC into battery electrolytes and semiconductor processing, and downstream into PCD/PUD coatings and now urethane prepolymers. - In nylon it has historically been integrated from benzene through cyclohexanone and caprolactam to nylon-6 polymer and compounded composites. The upstream part of this chain is being shut in Thailand (March 2026) and Japan (March 2027). - In elastomers it is a mid-sized polybutadiene producer supplying tyre makers. ### Customer types and end-markets | End-market | Representative UBE products | Notes | |---|---|---| | Electronics / displays / smartphones | Polyimide film (FPC, COF), polyimide varnish for OLED panels, BPDA, high-purity chemicals, semiconductor gases | UBE claims No. 1 global share in polyimide film for COF applications in LCD displays (company website) | | Automotive / EV / HEV | Li-ion separators (HEV-weighted), DMC/EMC electrolyte solvents, silicon-nitride bearing balls and substrates, nylon composites, polybutadiene (tyres), die-casting machines (incl. large "giga-cast" machines) | HEV demand drove separator growth in FY2026; EV slowdown hurt ceramics | | Energy / environment | CO2 separation membranes for biomethane, nitrogen membranes, low-carbon ammonia supply chain participation | Biomethane membranes hit by customer inventory adjustments in FY2026; recovery seen in Q1 FY2027 | | Industrial / mining / construction | Urethane cast elastomers (rollers, wheels, mining screens), industrial machinery (kilns, vertical mills, crushers, conveyors), bridges | Urethane systems strongest in the US | | Packaging / food | Nylon-6 for food-packaging film, polyethylene film | Weak overseas demand in FY2026 | | Agriculture | Ammonium sulphate fertiliser (by-product of caprolactam) | Shrinking with the caprolactam exit | | Pharmaceuticals | API and intermediate CDMO; drug discovery partnerships | Volumes fell 33% in FY2026 | ### Independent characterisation UBE is best understood as a "sum-of-the-parts in transition." The listed equity currently bundles five distinct things: 1. A sub-scale but technologically differentiated specialty-chemicals core (Functional Products plus Urethanes plus C1), earning roughly 9–16% segment margins. 2. A large, low-margin, cyclical "structural reform" commodity block (caprolactam, nylon, ammonia, elastomers), which generated about JPY 188 billion of sales in FY2026 at roughly breakeven. 3. A mid-cycle machinery business heading for IPO. 4. A 50% stake in a cement company heading for IPO, booked at about JPY 204 billion in investments in joint ventures. 5. A coal-fired power asset. The investment case depends on how quickly management can shrink item 2, monetise items 3 and 4, and redeploy capital into item 1 without destroying value through acquisition premiums. That last risk is real: FY2026 ROIC was 3.8% against an estimated 8% cost of equity.

Company Headquarters: Colombes, France Founded: 2003 Workforce: ~20,000 Company Working: Arkema is engaged in the manufacturing and supply of specialty chemicals and advanced materials. It operates through three segments: high-performance materials, industrials specialties, and coating solutions. The company offers value-added solutions to various markets including construction, electronics and electrical, food, agrochemicals, oil and gas, packaging and paper, renewable energies, transportation, water, health, hygiene, beauty, and sports. Hydrate inhibitors are offered under the industrial specialties segment. Arkema has 136 production sites and 15 research centers, with six R&D centers dedicated to sustainable development, in 55 countries across the globe.

Company Headquarters: Herrliberg, Switzerland Founded: 1936 Workforce: ~2,939 Company Working: EMS-Chemie Holding (EMS-Chemie) is engaged in the manufacturing and distribution of polymers and other chemical products. It operates through two business segments—high-performance polymers and specialty chemicals. The high-performance polymers segment comprises EMS-Grivory and EMS-Eftec. EMS-Grivory operates through three business units in Europe, the Americas, and Asia, and offers polyamide materials for the automotive and electrical & electronics industries, among others. The company provides polyamide 12 for numerous applications in electronics, sanitary fittings, fuel & air brake lines, and sheathing for fiber optical waveguides, and food & beverages. The company operates 26 production sites in around 16 countries, and sells products worldwide through distributors/traders.

Ecolab is the world's largest pure-play provider of water treatment, hygiene and infection-prevention solutions. It sells mission-critical chemistry, dispensing and monitoring equipment, digital analytics and on-site service, mostly under recurring, programme-based customer relationships. FY2025 net sales were $16.08bn. The mix by segment was: - Global Water: about 49% - Global Institutional & Specialty: about 38% - Global Pest Elimination: about 8% - Global Life Sciences: about 5% The company says it helps protect about one-third of the world's food production and about a quarter of global power generation. Under CEO Christophe Beck, Ecolab is moving its portfolio toward higher-growth, higher-margin "growth engines": Global High-Tech, Life Sciences, Pest Elimination and Ecolab Digital. The pivot accelerated in 2025–26 with two acquisitions: - Ovivo Electronics (ultrapure water for semiconductor fabs) - CoolIT Systems (direct-to-chip liquid cooling for AI data centres) Together these make Ecolab a full-stack "water-for-AI" supplier. The equity is valued as a quality compounder at about 34x 2026 adjusted EPS. The investment case rests on 12–15% EPS growth with margins above 20%. --- ### Company's own description (paraphrased from the FY2025 10-K and 2026 releases) Ecolab describes itself as a global leader in water, hygiene and infection-prevention solutions and services that protect people and vital resources. It says it combines science-based solutions, data-driven insights, AI technology and on-site service so that customers can define best-in-class operations and scale them across sites. The company lists its served markets as food, hospitality, healthcare, data centres, microelectronics, life sciences and heavy industry. It positions itself as "the world's water company" in the AI value chain, with three roles: - ultrapure water for chip fabrication - water treatment for the power plants that supply AI - direct liquid cooling for high-density compute Its 2030 impact goals are to help protect 2 billion people from infections and to conserve enough drinking water for 1 billion people (Q2-2026 release, "About Ecolab"). ### Business model and revenue model Ecolab's model is a razor/razor-blade service model with three layers: 1. **Consumable chemistry.** Detergents, sanitisers, water-treatment chemicals, process aids, pest products and purification resins. These are replenished continuously and drive most revenue and gross profit. 2. **Equipment.** Dispensers, controllers, sensors and liquid-cooling hardware. These are often placed at customer sites under lease or service arrangements, which creates switching costs. 3. **Field service and digital.** The 25,000-plus sales-and-service workforce audits, optimises and documents outcomes such as water saved, energy saved and regulatory compliance. Ecolab Digital (software and enabling hardware subscriptions) is a fast-growing overlay. **Characterisation of the mix:** - About 78% of revenue is product and equipment, though much of it is contractually recurring. - About 22% is service and lease. - Subscription revenue is a small but fast-growing slice. Ecolab Digital sales were $121m in Q2-2026, up 27% (8-K, 28 Jul 2026), implying a run-rate of roughly $0.45–0.5bn. - Licensing is not material. - The single largest product class is warewashing, at about 13% of FY2025 consolidated sales (10-K FY2025). ### Value-chain position Ecolab sits downstream of commodity and specialty chemical producers. Its main inputs are: - caustic soda, surfactants, phosphonates and polymers - solvents and resins - energy and plastics packaging It formulates, packages and distributes its products. It then captures margin through application know-how and service rather than molecule ownership. Pricing power comes from three sources: - customer total-cost-of-operation savings, which Ecolab quantifies as "value pricing" - the low cost of chemistry relative to the customer processes it protects (food safety, uptime, compliance) - embedded equipment and digital monitoring The 2026 energy surcharge shows both the pass-through ability and its lag. Organic gross margin dipped in early 2026 and then stabilised within one quarter (Q2-2026 release). ### Customer types and end-markets | End-market cluster | Typical customers | Segment | |---|---|---| | Heavy industry | Power generation, refining and downstream, chemicals, mining, primary metals | Global Water (Heavy Water) | | Light industry and commercial water | Manufacturing, commercial buildings, institutional campuses | Global Water (Light Water) | | High-Tech | Semiconductor fabs (ultrapure water), hyperscale and colocation data centres (cooling water, direct liquid cooling) | Global Water (High-Tech) | | Food & beverage processing | Dairy, protein, beverage, brewing, packaged food | Global Water (Food & Beverage) | | Pulp & paper | Paper and board mills | Global Water (Paper) | | Hospitality and foodservice | Full-service restaurants, hotels, lodging, contract foodservice | Global Institutional & Specialty | | Healthcare | Hospitals, long-term care | Global Institutional & Specialty (healthcare moved here in the 2025 realignment) | | Quick-service restaurants and food retail | QSR chains, grocery | Global Institutional & Specialty (Specialty) | | Pest-sensitive commercial sites | Restaurants, food retail, food plants, hospitality | Global Pest Elimination | | Biopharma and personal care | Bioprocessing, pharmaceutical manufacturing, personal care, industrial purification | Global Life Sciences | ### Independent characterisation Ecolab is best understood as a service-intensive specialty-chemicals compounder with three core features: - a defensive base: hospitality, food safety and healthcare hygiene, about 45% of sales - a cyclical but sticky industrial water franchise (Nalco, acquired 2011) - a set of secular-growth options FY2025 organic growth was about 3%. The company's long-term algorithm is 5–7% organic growth, 100–150 bps of annual operating-margin expansion, and 12–15% adjusted EPS growth. The 2026 acquisitions deliberately raise exposure to AI capital-expenditure cycles. That improves the growth mix but adds cyclicality and technology risk not historically present in the franchise.

Company Headquarters: Paris, France Founded: 1858 Workforce: ~88,775 Company Working: SUEZ specializes in providing water and waste management products and services. The company operates through five business segments, namely water Europe; recycling & recovery Europe; international; water technologies & solutions (WTS); and others. It offers chemicals, equipment, services (water distribution & treatment, and consulting), and engineering and construction contracts. Coagulants are offered under the water technologies & solutions business segment for applications such as industrial waste streams and influent clarification systems. It has operations in Europe and internationally.

Kemira is a Helsinki-headquartered, mid-cap specialty and commodity-adjacent chemicals producer that describes itself as a global leader in sustainable chemistry for water-intensive industries. With FY2025 revenue of EUR 2,753.5M and operative EBITDA of EUR 524.6M (19.1% margin), it is among the world's largest suppliers of water-treatment coagulants and polyacrylamide polymers. It is also a leading supplier of pulp bleaching chemicals (sodium chlorate, hydrogen peroxide) and of process and functional chemicals for packaging board, tissue and paper. After divesting Oil & Gas in February 2024, Kemira reorganised into three business units on 1 January 2025: Water Solutions (≈44% of revenue), Packaging & Hygiene Solutions (≈35%) and Fiber Essentials (≈20%). Its strategic ambition is to double water-related revenue, including a 2025 entry into US industrial water-treatment services. It also pursues EUR 500M+ of renewable-solutions revenue by 2030. The company is financially conservative (net debt/operative EBITDA 1.0x at end-2025) and is anchored by Oras Invest. In 2026 it is navigating a sharp, Iran-war-driven raw material and logistics cost shock. --- ### Company self-description (latest annual reporting, FY2025) Kemira presents itself as a global leader in sustainable chemistry for water-intensive industries. It serves municipal and industrial water-treatment customers and the fiber industry. Its solutions are positioned around securing clean water and supporting customers' circularity and resource-efficiency goals across their value chains. Its strategic pillars (as communicated since the 2024 strategy update) are profitable growth, with water as the principal growth engine, and renewable (bio-based) solutions as a long-term differentiation axis. ### Independent characterisation Kemira is best understood as a process-chemicals manufacturer with a "local-for-local" asset base. It operates 58 manufacturing facilities globally (FY2025 Board of Directors' Review). Its products are high-volume, relatively low-value-per-tonne chemicals (iron- and aluminium-based coagulants, sodium chlorate, hydrogen peroxide, caustic soda) where freight costs make proximity to customers a structural moat. These sit alongside higher-value functional chemistries (polyacrylamide flocculants, sizing agents such as AKD wax, dry- and wet-strength resins, defoamers, biocides, barrier chemistries). Value is added through application know-how, on-site service and, increasingly, digital dosing optimisation. The company's revenue model is overwhelmingly product sales under supply contracts. Water Solutions' municipal business is dominated by tendered, often fixed-price contracts, which explains the lag in passing through cost inflation highlighted in Q2 2026. Fiber Essentials sells bleaching chemicals under long-term agreements to pulp mills, in some cases from chemical "islands" co-located with customer mills. A nascent services revenue stream has been created through the acquisitions of Water Engineering, Inc. (October 2025), AquaBlue, Inc. (January 2026) and the Clear Water Technologies, LLC business (June 2026). These provide recurring industrial water-treatment programmes (boilers, cooling towers, wastewater) to food & beverage, healthcare, manufacturing, data-centre and commercial/institutional customers. Licensing revenue is immaterial and not separately disclosed. ### Revenue model mix (indicative) | Revenue type | Assessment | Basis | |---|---|---| | Product sales (chemicals) | Vast majority (>95%, analyst estimate) | Segment descriptions FY2025 | | Services (industrial water-treatment programmes) | Small but growing; Water Engineering acquired for approx. USD 150M; AquaBlue (<USD 10M deal value); Clear Water Technologies (2025 revenue slightly >USD 3M) | Company releases 2025–2026 | | Contract manufacturing | Included in Water Solutions "Industrial" segment (contract manufacturing for the acquirer of the Oil & Gas business) | FY2025 bulletin | | Licensing / subscription / digital | Not separately disclosed; digital services (e.g., KemConnect-type monitoring) bundled with chemistry | Company website | ### Value chain position Kemira sits in the mid-stream of the chemical value chain. It purchases basic inputs and converts them into formulated or commodity-grade process chemicals. Inputs include iron and aluminium sources (including industrial by-products such as iron sulphate from steel and TiO2 production), acrylonitrile/acrylamide-based monomers (oil-derived), electricity (critical for sodium chlorate electrolysis), salt, and fatty acids for AKD. Approximately one-third of raw materials are oil-based and mainly used for polymer production (June 2026 investor newsletter). Kemira is backward-integrated in electricity in Finland through shareholdings in Pohjolan Voima and Teollisuuden Voima (Mankala principle: power at production cost). This is a key cost advantage for energy-intensive sodium chlorate production. ### Customer types and end-markets | End-market | Customer type | BU | |---|---|---| | Municipal drinking water and wastewater | Water utilities, municipalities (Urban EMEA 26% and Urban Americas 23% of WS revenue) | Water Solutions | | Industrial water and wastewater | Manufacturing, food & beverage, mining, biogas/bioethanol, contract manufacturing (Industrial = 51% of WS revenue) | Water Solutions | | Industrial water services | Data centres, healthcare, commercial/institutional, property management | Water Solutions (New Ventures & Services) | | Packaging board, tissue, printing & writing paper | Board, tissue and paper mills (EMEA 43%, Americas 36%, APAC 21% of P&H revenue) | Packaging & Hygiene Solutions | | Bleached chemical pulp | Pulp producers (bleaching ≈70%, other base chemicals ≈30% of FE revenue) | Fiber Essentials | | Pharma intermediates | Sodium borohydride (Äetsä, Finland) | Fiber Essentials / specialty | | Textile fibre (emerging) | Metsä Group Kuura collaboration | Renewable solutions |

Acron Group — CNM

Company Headquarters: Zug, Switzerland Founded: 2001 Workforce: ~23,000 Company Working: EuroChem Group AG (EuroChem) manufactures and markets agricultural chemicals. The company produces nitrogen, phosphate, and NPK fertilizers, as well as offers feed phosphates, industrial acids, and mineral raw materials. It operates production facilities in Belgium, China, Kazakhstan, Lithuania, and Russia. It operates through 4 segments, namely, mining, fertilizers, commercial, and others. It has seven production sites for fertilizers spread across the US, Germany, Russia, and China. The sales and distribution operations of the company span across five regions: Europe, Russia/CIS, North America, Latin America, and Asia. It has an annual capacity of 350,000 tonnes of ammonia production.

Company Headquarters: Amsterdam, Netherlands Founded: 2013 Workforce: ~3,600 Company Working: OCI NV is a leading global producer and distributor of nitrogen products providing sustainable solutions to agricultural and industrial customers around the world. Its production capacity spans 4 continents and comprises approximately 16.1 million metric tons per year of nitrogen fertilizers, methanol, diesel exhaust fluid, melamine, and other nitrogen products. It operates 9 production sites globally. It operates through business segments, namely, Nitrogen Europe, Nitrogen US, Methanol US, Methanol Europe, Fertiglobe, and others. The company has started production of green ammonia in 2019 through its Dutch fertilizer complex with an annual capacity of 6.9 million metric tons. It offers ammonia under its Fertiglobe segment and sold 2.1 million metric tons of ammonia in 2019. Its fertilizer distribution infrastructure includes a wholly owned ammonia export terminal at the port of Rotterdam, warehousing capacity across the US, Europe, the Middle East and North Africa, rail car fleets in the US and Europe, and a 15 KT ammonia vessel.

Nutrien is the world's largest crop-input company by integrated scope. It combines the world's largest potash capacity with a top-tier North American nitrogen franchise, a smaller phosphate business, and the world's largest agricultural retail network, Nutrien Ag Solutions. Six Saskatchewan potash mines give it about 20% of global potash nameplate capacity (2025 AIF). Its gas-advantaged North American nitrogen plants supply ammonia, urea, ESN® and upgraded solutions to agricultural and industrial buyers. The retail network of about 1,700–1,800 locations across the US, Canada, Australia and South America sells nutrients, crop protection, seed, services and financing to roughly half a million grower accounts, with a growing proprietary-products margin layer. The investment case rests on a cost-advantaged, long-life upstream asset base, earnings that are less volatile than pure-play producers because of retail, and a 2024–2026 "simplify and focus" program. That program is exiting non-core assets (Profertil, Sinofert, Trinidad and New Madrid nitrogen, with Phosphate and Brazil retail under review) to lift free cash flow and shareholder returns. --- **Company's own description (FY2025 annual report / Q2 2026 MD&A).** Nutrien describes itself as a leading global provider of crop inputs and services. It says it operates a world-class network of production, distribution and ag retail facilities positioned to serve farmers efficiently. Its stated vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. The strategy rests on three priorities: simplify and focus, operational excellence, and disciplined, intentional capital allocation. Management says the strategy is designed to produce low-risk, structural free-cash-flow growth and reliable, growing cash returns to shareholders. **Business model.** Nutrien is vertically integrated across the crop-nutrient value chain: **Upstream (Potash, Nitrogen, Phosphate):** mining and chemical manufacturing of the three primary crop macronutrients. In 2025 the company sold about 27.5 million tonnes of manufactured fertilizer from plants in Canada, the US and Trinidad (2025 AIF). **Midstream:** global sales, freight, transportation and distribution, reported inside each upstream segment. Offshore potash is sold exclusively through Canpotex, the export marketing joint venture Nutrien shares 50/50 with Mosaic. **Downstream (Retail / Nutrien Ag Solutions):** direct-to-grower distribution of crop nutrients, crop protection products, seed and merchandise. Retail also provides agronomy services (application, soil sampling, variable-rate prescriptions, crop monitoring by more than 4,200 crop consultants) and financing through Nutrien Financial. It manufactures about 1,700 proprietary products at eight formulation facilities. **Revenue model mix.** Nutrien is overwhelmingly a product company. Services and financing are small but higher margin. *Derived from FY2025 Q4 release segment and product-line tables. Retail product sales = 7,285 + 6,105 + 2,128 + 875. Nutrien Financial net = 376 − 93. Upstream third-party = 3,571 + 3,807 + 1,660. No subscription or licensing revenue of significance is disclosed.* **Value-chain position.** Nutrien is one of very few companies present from mine and plant gate through to the farm gate. That integration lets it capture producer economics in tight markets (upstream generated about 74% of FY2025 segment adjusted EBITDA) and distribution economics in weak markets (Retail EBITDA is comparatively stable at US$1.4–2.3 billion through the cycle). **Customer types.** **End-markets served:** global grain and oilseed production (the main driver), livestock (Australia), industrial nitrogen (mining, chemicals, diesel exhaust fluid), feed phosphates and industrial phosphoric acid. **Independent characterization.** Nutrien is best understood as a cash-generative, cost-advantaged potash franchise and an efficient North American nitrogen producer, attached to a large, lower-margin but steady distribution business. Pure-play peers cannot replicate the integration, but it has historically weighed on valuation through retail capital intensity, Brazil losses and conglomerate complexity. Under CEO Ken Seitz (since 2022), the company has shifted from growth acquisitions (2018–2022) to portfolio pruning, cost-out and capital returns. The FY2025 results (adjusted EBITDA US$6.05 billion, +13%; free cash flow about US$2.0 billion) and H1 2026 results (adjusted EBITDA US$3.54 billion, +6%) suggest that pivot is gaining traction. The open question is whether the Phosphate review and the 30 November 2026 Investor Day produce a structurally simpler potash–nitrogen–retail company.

Company Headquarters: Deerfield, US Founded: 1946 Workforce: ~3,000 Company Working: CF Industries Holdings, Inc. (CF Industries) a global leader in nitrogen fertilizer manufacturing and distribution. It operates through the following business segments, ammonia, granular urea, urea ammonium nitrate solution (UAN), ammonium nitrate (AN), and others. The others segment includes nitrogen products such as diesel exhaust fluid (DEF), urea liquor, nitric acid, and aqua ammonia. The company produced 10.25 million tons of ammonia as of December 2019. It operates 70 manufacturing plants, out if which 28 are for ammonia, 40 are for UAN, and rest for granular urea.

Company Headquarters: Oslo, Norway Founded: 1905 Workforce: 16,757 Company Working: Yara is the world’s leading fertilizer company and the second-largest producer of ammonia in the world. As a part of its crop nutrition-focused strategy, Yara has simplified its operating model and changed its operating business segments effective from 1 January 2019. The new segment structure is comprised of three segments, namely sales & marketing, new business, and production. The sales & marketing segment includes the crop nutrition, base chemicals, industry reagents, and animal nutrition (excluding South Africa) business units. The “new business” segment includes the environmental solutions, mining applications, animal nutrition - South Africa, and industrial nitrates business units. Under the sales & marketing and the new business segments, the company offers feed acidifiers through the animal nutrition sub-division. Yara has 28 production plants, 200 infrastructure points, and 10,800 Yara-branded retail outlets worldwide. It has production sites in six continents, market operations in more than 60 countries, and sales operations in about 160 countries globally.

Company Headquarters: Midland, US Founded: 1883 Workforce: ~98,000 Company Working: DowDuPont is a holding company that develops agricultural products, specialty materials, and chemicals. It operates through 534 manufacturing sites and the agriculture, performance materials and coatings, industrial intermediates and infrastructure, packaging and specialty plastics, electronics and imaging, nutrition and biosciences, transportation and advanced polymers, and safety and construction segments. DowDuPont planned to create three independent companies called Corteva Agriscience, Dow, and New DuPont, where Covetra Agriscience will represent the agriculture division of the company, while Dow will represent the materials science division, and New DuPont the specialty products division. In April 2019, DowDuPont completed separation of materials science division through the spin-off of Dow Inc and is likely to complete the separation of its agriculture division in June 2019.

LANXESS is a mid-cap German specialty chemicals group. It was carved out of Bayer in 2004 and over two decades has transformed from a cyclical rubber- and plastics-heavy portfolio into a three-segment specialty chemicals company: Consumer Protection, Specialty Additives and Advanced Intermediates. The transformation has been completed in sequence. The rubber exit came via ARLANXEO (2016–2018). Engineering plastics were contributed to the Envalior joint venture (2023). Urethane Systems was sold to UBE (April 2025). LANXESS now describes itself as a pure specialty-chemicals provider. The group holds globally relevant positions in several niches: - bromine-based flame retardants - biocides and material protection - benzoic acid and benzoate derivatives - ion-exchange resins (Lewatit) - iron-oxide pigments (Bayferrox) - lubricant and rubber additives - aromatic intermediates for agrochemicals The investment case today is a deleveraging and self-help story. FY2025 sales were EUR 5.67bn and EBITDA pre was EUR 510m. Net debt is about 4x EBITDA pre, and the rating is sub-investment-grade at Moody's. The equity value is now comparable to the book value of LANXESS's 40.94% Envalior stake. Value realisation hinges on the Envalior exit (2027/2028), EUR 150m of structural cost savings and a European chemicals recovery. --- ### What the company does LANXESS develops, manufactures and markets three groups of products: - chemical intermediates (aromatics, amines, nitro and chlorinated aromatics, inorganic pigments) - additives (flame retardants, plasticisers, lubricant additives, rubber chemicals) - consumer protection products (biocides, disinfectants, preservatives, aroma chemicals, benzoates, ion-exchange resins, custom synthesis) Following the April 2025 Urethane Systems sale, the group reports three segments: Consumer Protection (CP), Specialty Additives (SA) and Advanced Intermediates (AI). It also holds a 40.94% equity-accounted stake in Envalior, the engineering-materials joint venture with Advent International. **Company's own description (paraphrased from corporate boilerplate and the 2024 Annual Report).** LANXESS describes itself as a leading specialty chemicals company whose core business is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. It operates in around 32 countries. ### Business model and revenue model | Revenue model element | Characterisation | |---|---| | Product vs. service mix | Close to 100% product sales (B2B chemical products sold by weight or volume). Service-like revenue is limited to custom manufacturing (toll and exclusive synthesis at Saltigo) and application and technical support bundled with products. | | Subscription / licensing | Not material; no licensing revenue is disclosed | | Contracting | Mix of annual and multi-year supply agreements (agro intermediates, custom synthesis) and spot or quarterly pricing (commodity-linked intermediates, pigments). Raw-material and energy pass-through clauses apply in parts of the portfolio. | | Pricing model | Cost-plus with indexation in intermediates. Value-based pricing in specialties (biocides, flame retardants, ion-exchange resins). Periodic list-price increases, e.g. a 6–8% increase on Lewatit resins in spring 2026. | ### Value-chain position LANXESS sits mid-chain. It buys petrochemical feedstocks (benzene, toluene, chlorine, ammonia, cyclohexane) and minerals (bromine brines at El Dorado, Arkansas; iron sources for pigments). It converts these into intermediates and functional additives that customers formulate into their own end products. These customers include agrochemical majors, coatings and construction-materials producers, plastics compounders, lubricant blenders, tyre makers, and personal-care and household brands. A significant share of Advanced Intermediates output is captive or quasi-captive: it feeds downstream LANXESS units (Saltigo, MPP, Polymer Additives) in integrated German Verbund sites at Leverkusen, Krefeld-Uerdingen and Dormagen. ### Customer types and end-markets | End-market | Exposure (qualitative) | Comment | |---|---|---| | Agrochemicals | High (Saltigo, AII aromatic intermediates, MPP actives) | Agro is about 70–80% of Saltigo sales (Q2 2026 call). Generic agro is under Chinese and Indian price pressure. | | Construction | High (Bayferrox pigments, flame retardants, plasticisers, biocides for paints) | The company expects a construction recovery in 2027 and has removed construction upside from its 2026 guidance | | Automotive / transport | Medium (lubricant additives, rubber chemicals, AII products) | Reduced to approx. 10% of revenues after the Envalior carve-out (investor estimate, MOI Global 2024) | | Consumer / personal care / household | Medium (benzoates, aroma chemicals, preservatives, disinfectants) | Most defensive pocket; CP margins rose to 15.4% in FY2025 | | Water treatment / energy / food | Medium (Lewatit ion-exchange resins) | Structural growth niche | | Pharma / specialty / electronics | Low but targeted (Saltigo pivot) | Management sees these as higher-margin growth markets for Saltigo | | Electronics, E&E, plastics (flame retardants) | Medium | Bromine and phosphorus flame retardants | The company has repeatedly identified agrochemicals, construction and automotive as the end-markets that drove the 2023–2025 downturn. The CEO's comment on Q3 2025 named these three as the most difficult. **Independent characterisation.** Despite the "specialty" label, LANXESS is in practice a hybrid. Roughly 40% of sales (Consumer Protection plus parts of Specialty Additives) behave like true specialties, with pricing power, low capital intensity and 13–16% margins. Roughly 30% (Advanced Intermediates) remains a scale- and energy-intensive commodity-to-semi-specialty business that is exposed to Asian overcapacity and German energy costs. The group's EBITDA margin pre exceptionals has compressed from 13.4% (FY2021, continuing operations) to 9.0% (FY2025). This is well below specialty peers and is the core reason for the de-rating.